💊 Thuốc A-Z 🧬 Đích tác dụng 🛠 Công cụ 📚 Hướng dẫn
Tất cả thuốc Phân loại thuốc Lĩnh vực điều trị Tác dụng phụ
Hướng dẫn Từ điển thuật ngữ Dòng thời gian
So sánh Hành trình của thuốc Các họ thuốc
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Technetium Tc 99M Sestamibi

CHEMBL6067977 Phase 4 Đã phê duyệt Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
777.9 g/mol
LogP
—
Phase
4

Technetium Tc 99m sestamibi is the most widely used myocardial perfusion imaging agent, accumulating in viable, well-perfused myocardium proportional to blood flow and mitochondrial membrane potential. See technetium-sestamibi for complete pharmacological details. It is also used for parathyroid adenoma localization and adjunctive breast imaging.

Khối lượng phân tử

777,9000 g/mol

TPSA

81,50 Ų

Lĩnh vực điều trị

Ovarian Cancer Thyroid Cancer Non-Small Cell Lung Cancer Type 2 Diabetes Breast Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.CC(C)(C[N+]#[C-])OC.[99Tc]

InChI

InChI=1S/6C6H11NO.Tc/c6*1-6(2,8-4)5-7-3;/h6*5H2,1-2,4H3;/i;;;;;;1+1

Molecular Formula

C36H66N6O6Tc

HBD / HBA

- / 12

Liên kết có thể quay

12

Nguyên tử nặng

49

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

Technetium Tc 99m sestamibi is the most widely used myocardial perfusion imaging agent, accumulating in viable, well-perfused myocardium proportional to blood flow and mitochondrial membrane potential. See technetium-sestamibi for complete pharmacological details. It is also used for parathyroid adenoma localization and adjunctive breast imaging.

Yes, Technetium Tc 99M Sestamibi is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6067977. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 449763. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.